Nephros, Inc. (NEPH)
NASDAQ: NEPH · Real-Time Price · USD
3.470
-0.220 (-5.96%)
At close: May 22, 2026, 4:00 PM EDT
3.570
+0.100 (2.88%)
After-hours: May 22, 2026, 7:58 PM EDT
Nephros Employees
Nephros had 36 employees as of December 31, 2025. The number of employees increased by 5 or 16.13% compared to the previous year.
Employees
36
Change (1Y)
5
Growth (1Y)
16.13%
Revenue / Employee
$531,222
Profits / Employee
$21,556
Market Cap
37.67M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 36 | 5 | 16.13% | 36 | 0 |
| Dec 31, 2024 | 31 | 0 | - | 31 | 0 |
| Dec 31, 2023 | 31 | 4 | 14.81% | 31 | 0 |
| Dec 31, 2022 | 27 | -7 | -20.59% | 27 | 0 |
| Dec 31, 2021 | 34 | 7 | 25.93% | 34 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Harvard Bioscience | 339 |
| Jin Medical International | 273 |
| Retractable Technologies | 227 |
| Bionano Genomics | 97 |
| Precision Optics Corporation | 90 |
| Sharps Technology | 55 |
| Femasys | 54 |
| Microbot Medical | 43 |
NEPH News
- 15 days ago - Nephros Earnings Call Transcript: Q1 2026 - Transcripts
- 15 days ago - Nephros Quarterly report: Q1 2026 - Filings
- 15 days ago - Nephros Earnings release: Q1 2026 - Filings
- 15 days ago - Nephros Announces Financial Results for Quarter Ended March 31, 2026 - GlobeNewsWire
- 22 days ago - Nephros Schedules First Quarter 2026 Financial Results Conference Call - GlobeNewsWire
- 7 weeks ago - Nephros Expands Water Safety Capabilities With ASSE 12080 Certified Water Management Planning Expertise - GlobeNewsWire
- 2 months ago - Nephros Slides: Corporate presentation - Filings
- 2 months ago - Nephros Earnings Call Transcript: Q4 2025 - Transcripts